{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:32:37Z","timestamp":1771867957082,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"JSPS KAKENHI","award":["16OH2684"],"award-info":[{"award-number":["16OH2684"]}]},{"name":"JSPS KAKENHI","award":["18OH5386"],"award-info":[{"award-number":["18OH5386"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.peptides.2020.170332","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T02:50:39Z","timestamp":1590029439000},"page":"170332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Pituitary adenylate cyclase-activating polypeptide: Protective effects in stroke and dementia"],"prefix":"10.1016","volume":"130","author":[{"given":"Naoko","family":"Nonaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4164-6743","authenticated-orcid":false,"given":"Seiji","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2020.170332_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-802973-2.00008-2","article-title":"Dementias","volume":"138","author":"Sacuiu","year":"2016","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.peptides.2020.170332_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0167-0115(92)90621-Z","article-title":"Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research","volume":"37","author":"Arimura","year":"1992","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2020.170332_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.peptides.2020.170332_bib0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","article-title":"Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells","volume":"164","author":"Miyata","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2020.170332_bib0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0006-291X(90)92140-U","article-title":"Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues(PACAP38)","volume":"170","author":"Miyata","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2020.170332_bib0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1749-6632.1996.tb17489.x","article-title":"Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons","volume":"805","author":"Banks","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2020.170332_bib0035","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12031-014-0309-4","article-title":"PACAP38 suppresses cortical damage in mice with traumatic brain injury by enhancing antioxidant activity","volume":"54","author":"Miyamoto","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.peptides.2020.170332_bib0040","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/neu.2011.2244","article-title":"Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4\/MyD88\/NF-\u03baB pathway","volume":"29","author":"Mao","year":"2012","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.peptides.2020.170332_bib0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-8993(96)00716-0","article-title":"Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide","volume":"736","author":"Uchida","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2020.170332_bib0050","doi-asserted-by":"crossref","first-page":"13355","DOI":"10.1073\/pnas.231094498","article-title":"Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide(PACAP)","volume":"98","author":"Hashimoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.peptides.2020.170332_bib0055","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1073\/pnas.0600375103","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6","volume":"103","author":"Ohtaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.peptides.2020.170332_bib0060","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jnr.21065","article-title":"Pituitary adenylate cyclase-activating polypeptide-induced differentiation of embryonic neural stem cells into astrocytes is mediated via the beta isoform of protein kinase C","volume":"84","author":"Watanabe","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.peptides.2020.170332_bib0065","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1007\/s12035-016-0204-9","article-title":"PACAP protects the adolescent and adult mice brain from ethanol toxicity and modulates distinct sets of genes regulating similar networks","volume":"54","author":"Lacaille","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.peptides.2020.170332_bib0070","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1073\/pnas.082112699","article-title":"Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death","volume":"99","author":"Vaudry","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.peptides.2020.170332_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011091","article-title":"Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells","volume":"5","author":"M\u00e4kel\u00e4","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170332_bib0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fnmol.2018.00493","article-title":"Neuropeptides exert neuroprotective effects in Alzheimer\u2019s disease","volume":"11","author":"Chen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.peptides.2020.170332_bib0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.peptides.2015.08.006","article-title":"PACAP as a neuroprotective factor in ischemic neuronal injuries","volume":"72","author":"Shioda","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2020.170332_bib0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.1998.tb11169.x","article-title":"PACAP protects hippocampal neurons against apoptosis: involvement of JNK\/SAPK signaling pathway","volume":"865","author":"Shioda","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2020.170332_bib0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5483\/BMBRep.2014.47.7.086","article-title":"Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases","volume":"47","author":"Lee","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.peptides.2020.170332_bib0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1515\/cmble-2015-0008","article-title":"Therapeutic potential of PACAP for neurodegenerative diseases","volume":"20","author":"Yang","year":"2015","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.peptides.2020.170332_bib0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biochi.2010.12.010","article-title":"Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP","volume":"93","author":"Dejda","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.peptides.2020.170332_bib0110","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.neurobiolaging.2014.03.022","article-title":"Pituitary adenylate cyclase-activating polypeptide protects against \u03b2-amyloid toxicity","volume":"35","author":"Han","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.peptides.2020.170332_bib0115","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12031-012-9817-2","article-title":"Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury","volume":"48","author":"Tsuchikawa","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.peptides.2020.170332_bib0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitement of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke","volume":"82","author":"Knowland","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.peptides.2020.170332_bib0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1023\/A:1021067822435","article-title":"Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats","volume":"22","author":"Abrah\u00e1m","year":"2002","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.peptides.2020.170332_bib0130","series-title":"Pathological Alterations of the Blood-brain Barrier. In Blood-brain Barrier in Physiology and Medicine 129-152","author":"Rapoport","year":"1976"},{"key":"10.1016\/j.peptides.2020.170332_bib0135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0022-3565(25)39457-7","article-title":"Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier","volume":"267","author":"Banks","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2020.170332_bib0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-3-319-35135-3_25","article-title":"Transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barriers: consequences for disease states and therapeutic effects. Pituitary adenylate cyclase activating polypeptide-PACAP","volume":"11","author":"Banks","year":"2016","journal-title":"Curr. Top. Neurotox."},{"key":"10.1016\/j.peptides.2020.170332_bib0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/path.5100","article-title":"Accelerated pre-senile systemic amyloidosis in PACAP knockout mice-a protective role of PACAP in age-related degenerative processes","volume":"245","author":"Reglodi","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.peptides.2020.170332_bib0150","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0196-9781(02)00248-6","article-title":"Regional differences in PACAP transport across the blood-brain barrier in mice: a possible influence of strain, amyloid beta protein, and age","volume":"23","author":"Nonaka","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2020.170332_bib0155","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.0000000000000417","article-title":"Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease","volume":"82","author":"Han","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.peptides.2020.170332_bib0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11357-018-0045-8","article-title":"PACAP deficiency as a model of aging","volume":"40","author":"Reglodi","year":"2018","journal-title":"Geroscience"},{"key":"10.1016\/j.peptides.2020.170332_bib0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaneurol.2014.3625","article-title":"Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease","volume":"72","author":"Han","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.peptides.2020.170332_bib0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0031-6997(24)01449-2","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"Vaudry","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.peptides.2020.170332_bib0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0168-0102(97)00065-5","article-title":"Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain","volume":"28","author":"Shioda","year":"1997","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.peptides.2020.170332_bib0180","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.peptides.2007.06.029","article-title":"Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development","volume":"28","author":"Watanabe","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2020.170332_bib0185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/138161211795589346","article-title":"Role of PACAP in neural stem\/progenitor cell and astrocyte--from neural development to neural repair","volume":"17","author":"Nakamachi","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.peptides.2020.170332_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120526","article-title":"PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF","volume":"10","author":"Ogata","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170332_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00294-0","article-title":"Distribution of pituitary adenylate cyclase activating polypeptide mRNA in the developing rat brain","volume":"65","author":"Skogl\u00f6sa","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.peptides.2020.170332_bib0200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1096-9861(20001002)425:4<495::AID-CNE3>3.0.CO;2-A","article-title":"Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development","volume":"425","author":"Basille","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.peptides.2020.170332_bib0205","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1523\/JNEUROSCI.23-06-02274.2003","article-title":"Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide","volume":"23","author":"Guirland","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2020.170332_bib0210","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0306-4522(96)00617-3","article-title":"Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts","volume":"78","author":"Gonzalez","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2020.170332_bib0215","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/brainsci7060062","article-title":"Postnatal migration of cerebellar interneurons","volume":"7","author":"Galas","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.peptides.2020.170332_bib0220","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/3305","article-title":"Neurogenesis in the adult human hippocampus","volume":"4","author":"Eriksson","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2020.170332_bib0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0092-8674(02)00862-0","article-title":"Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors","volume":"110","author":"Nakatomi","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2020.170332_bib0230","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.7754370","article-title":"A neuropeptide gene defined by the Drosophila memory mutant amnesiac","volume":"268","author":"Feany","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.peptides.2020.170332_bib0235","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1523\/JNEUROSCI.19-20-08740.1999","article-title":"Developmental expression of an amn(+) transgene rescues the mutant memory defect of amnesiac adults","volume":"19","author":"DeZazzo","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2020.170332_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/nlme.2001.4014","article-title":"Pituitary adenylate cyclase-activating polypeptide hormone (PACAP) at very low dosages improves memory in the rat","volume":"76","author":"Sacchetti","year":"2001","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.peptides.2020.170332_bib0245","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature22067","article-title":"Human umbilical cord plasma proteins revitalize hippocampal function in aged mice","volume":"544","author":"Castellano","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2020.170332_bib0250","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12031-016-0731-x","article-title":"Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) is involved in adult mouse hippocampal neurogenesis after stroke","volume":"59","author":"Matsumoto","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.peptides.2020.170332_bib0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-8993(00)02579-8","article-title":"The action of pituitary adenylate cyclase activating polypeptide (PACAP) on passive avoidance Learning.The role of transmitters","volume":"874","author":"Telegdy","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2020.170332_bib0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2004.09.013","article-title":"Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier","volume":"191","author":"Nonaka","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.peptides.2020.170332_bib0265","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/jcbfm.2008.131","article-title":"Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models","volume":"29","author":"Dogrukol-Ak","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.peptides.2020.170332_bib0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.peptides.2012.05.021","article-title":"Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins","volume":"36","author":"Nonaka","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2020.170332_bib0275","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.peptides.2020.170332_bib0280","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1096\/fj.10-180133","article-title":"Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer\u2019s disease-like pathology in amyloid precursor protein-transgenic mice","volume":"25","author":"Rat","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2020.170332_bib0285","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.peptides.2008.01.022","article-title":"Novel stable PACAP analogs with potent activity towards the PAC1 receptor","volume":"29","author":"Bourgault","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2020.170332_bib0290","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fncel.2019.00524","article-title":"Pituitary adenylate cyclase-activating polypeptide modulates hippocampal synaptic transmission and plasticity: new therapeutic suggestions for fragile X syndrome","volume":"13","author":"Ciranna","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.peptides.2020.170332_bib0295","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120300814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120300814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:26:14Z","timestamp":1759310774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978120300814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":59,"alternative-id":["S0196978120300814"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170332","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary adenylate cyclase-activating polypeptide: Protective effects in stroke and dementia","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170332"}}